Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome

NCT ID: NCT01748448 Phase: PHASE3 Status: COMPLETED Enrollment: 436 Completion: 2022-07

Conditions

Cutaneous Malignant Melanoma

Interventions

Vitamin D, Placebo: Oil

Summary

To assess whether vitamin D supplementation after surgery of a first cutaneous malignant melanoma protects against relapse of the disease.

Primary Outcome

Relapse Free Survival

Source

ClinicalTrials.gov